Microfluidics News and Research

RSS

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with the Agency for Science, Technology and Research (A*STAR) Bioprocessing Technology Institute (BTI) and National University Health System (NUHS), have developed a groundbreaking technology capable of extracting mesenchymal stem cells (MSCs) directly from pure bone marrow – also known as bone marrow aspirate (BMA), a pivotal source of MSCs – without dilution.

20 Nov 2023

New technique helps 'visualize' osmotic pressure within living embryonic tissues

In order to survive, organisms must control the pressure inside them, from the single-cell level to tissues and organs.

3 Nov 2023

Sphere Bio's Expansion and Vision

In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics' new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.

From Fluidic Sciences and Sphere Bio 25 Oct 2023

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Laura Kuett, a Ph.D. student in Systems Biology, about the promise of 3D Imaging Mass Cytometry.

17 Oct 2023

HMS researcher to lead $104 million effort to study bacteria and antibiotic resistance

Harvard Medical School researcher Johan Paulsson will lead a multi-institutional $104 million effort to study bacteria and antibiotic resistance, the U.S. Department of Health and Human Services announced today.

27 Sep 2023

NGS made effortless: introducing MIRO CANVAS from INTEGRA Biosciences

INTEGRA Biosciences is excited to announce the launch of MIRO CANVAS, a compact digital microfluidics platform for fully automated next-generation sequencing (NGS) sample preparation.

From INTEGRA Biosciences 22 Sep 2023

Capture and release of tumor cells using a bioelectronic device

In the book entitled Microfluidic Systems for Cancer Diagnosis, the UPV/EHU’s Microfluidics Cluster group describes the process for building a bioelectronic device consisting of gold electrodes coated with a smart polymer capable of capturing and releasing cells in a non-invasive, controllable way while monitoring the processes using conventional electrical measurements.

8 Sep 2023

Unleashing the Power of Microfluidic Picodroplets

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Richard Hammond, Chief Technical Officer at Sphere Bio, about their microfluidic picodroplet technology and more.

From Fluidic Sciences and Sphere Bio 21 Aug 2023

New Bactometer device offers rapid, accurate detection of bacteria

Bactometer is a biological detector that if used as screening system, will provide a valuable support in the battle against antimicrobial resistance in Hospital environments.

18 Aug 2023

Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Researchers presented a scalable lipid nanoparticle production (SCALAR) platform to develop SARS-CoV-2 mRNA lipid nanoparticle vaccines.

15 Aug 2023

Lab-on-a-chip technologies offer new ways to assess stored red blood cells

Ziya Isiksacan, PhD, a research fellow in the Center for Engineering in Medicine and Surgery (CEMS) is the lead author, and Osman Berk Usta, PhD, an investigator in the CEMS at Massachusetts General Hospital and an associate professor of Surgery at Harvard Medical School, is the senior author of a new study published in PNAS, Assessment of Stored Red Blood Cells Through Lab-on-a-Chip Technologies for Precision Transfusion Medicine.

26 Jul 2023

Unchained Labs goes all in on Lipid Nanoparticles, acquires Blacktrace Holdings

Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired Blacktrace Holdings today.

From Unchained Labs 21 Jul 2023

New AI-aided biosensor developed to detect neurodegenerative diseases

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases (NDDs) such as Parkinson's disease (PD) and Alzheimer's disease (AD).

12 Jul 2023

New method could revolutionize the delivery of antioxidants to stem cells

As we age, our bodies change and degenerate over time in a process called senescence. Stem cells, which have the unique ability to change into other cell types, also experience senescence, which presents an issue when trying to maintain cell cultures for therapeutic use.

27 Jun 2023

Microfluidics News and Research

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

New technique helps 'visualize' osmotic pressure within living embryonic tissues

Sphere Bio's Expansion and Vision

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

HMS researcher to lead $104 million effort to study bacteria and antibiotic resistance

NGS made effortless: introducing MIRO CANVAS from INTEGRA Biosciences

Capture and release of tumor cells using a bioelectronic device

Unleashing the Power of Microfluidic Picodroplets

New Bactometer device offers rapid, accurate detection of bacteria

Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Lab-on-a-chip technologies offer new ways to assess stored red blood cells

Unchained Labs goes all in on Lipid Nanoparticles, acquires Blacktrace Holdings

New AI-aided biosensor developed to detect neurodegenerative diseases

New method could revolutionize the delivery of antioxidants to stem cells

U.S. patent granted for novel tool designed to reliably diagnose and monitor sickle cell disease

Transforming antibiotic resistance testing: a novel, rapid and affordable technique

Paving the Way for New Drugs through Particle Perfection

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer

Lipid Nanoparticles (LNPs) and DNA delivery – unlocking the future of medical research

New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

What are the challenges of cell line development? eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo